Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Aerpio Pharmaceuticals Inc (ARPO)

Aerpio Pharmaceuticals Inc (ARPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 104,852
  • Shares Outstanding, K 47,660
  • Annual Sales, $ 15,000 K
  • Annual Income, $ -4,320 K
  • 60-Month Beta 1.69
  • Price/Sales 7.05
  • Price/Cash Flow N/A
  • Price/Book 2.97
Trade ARPO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.37
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/11/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.40
  • Number of Estimates 1
  • High Estimate -0.40
  • Low Estimate -0.40
  • Prior Year -0.12
  • Growth Rate Est. (year over year) -233.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.98 +11.39%
on 08/04/21
2.68 -17.91%
on 08/17/21
+0.08 (+3.77%)
since 07/26/21
3-Month
1.62 +35.80%
on 06/29/21
3.32 -33.73%
on 07/08/21
+0.51 (+30.18%)
since 05/26/21
52-Week
0.95 +130.58%
on 05/10/21
3.32 -33.73%
on 07/08/21
+0.72 (+48.65%)
since 08/26/20

Most Recent Stories

More News
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement

LOS ANGELES, Aug. 26, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”) (Nasdaq: AADI), a clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers...

ARPO : 33.00 (-0.90%)
AADI : 1.7100 (-1.16%)
Aerpio Reports Second Quarter 2021 Financial Results and Provides Business Update

CINCINNATI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company, today reported financial results for the three and six months ended...

ARPO : 33.00 (-0.90%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates ARPO, FBNC, KIN, HOME; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / July 3, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Aerpio Pharmaceuticals, Inc. (NASDAQ:ARPO) concerning...

ARPO : 33.00 (-0.90%)
FBNC : 30.95 (+3.89%)
KIN : 9.25 (+0.11%)
HOME : 36.99 (-0.08%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of ARPO, ONDS, CORE, and DEH Mergers

WILMINGTON, Del., July 02, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating:

ARPO : 33.00 (-0.90%)
ONDS : 0.8443 (-2.28%)
CORE : 45.65 (-0.76%)
DEH : 11.57 (+4.23%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds ARPO, ONDS, CHMA, and PFOH Shareholders About Its Ongoing Investigations

NEW YORK, June 24, 2021 (GLOBE NEWSWIRE) --

ARPO : 33.00 (-0.90%)
ONDS : 0.8443 (-2.28%)
CHMA : 3.76 (-6.00%)
PFOH : 40.2000 (+0.50%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CORE, ARPO, MMAC, ONB; Shareholders are Encouraged to Contact the Firm

NEW YORK, June 21, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CORE : 45.65 (-0.76%)
ARPO : 33.00 (-0.90%)
MMAC : 27.77 (+0.04%)
ONB : 16.36 (+2.70%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds MFNC, CORE, ALTA, and ARPO Shareholders About Its Ongoing Investigations

NEW YORK, June 17, 2021 (GLOBE NEWSWIRE) --

MFNC : 21.50 (+0.56%)
CORE : 45.65 (-0.76%)
ALTA : 44.16 (-1.25%)
ARPO : 33.00 (-0.90%)
SHAREHOLDER ALERT: WeissLaw LLP Reminds CORE, ALTA, ARPO, and ONDS Shareholders About Its Ongoing Investigations

NEW YORK, June 10, 2021 (GLOBE NEWSWIRE) --

CORE : 45.65 (-0.76%)
ALTA : 44.16 (-1.25%)
ARPO : 33.00 (-0.90%)
ONDS : 0.8443 (-2.28%)
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Reminds Investors of Investigation of ARPO, CORE, UFS, and EQT Mergers

WILMINGTON, Del., June 10, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. announces that it is investigating:

EQT : 40.75 (-1.02%)
UFS : 55.49 (+0.02%)
CORE : 45.65 (-0.76%)
ARPO : 33.00 (-0.90%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ARPO, ALTA, MMAC, SBBP; Shareholders are Encouraged to Contact the Firm

NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

ARPO : 33.00 (-0.90%)
ALTA : 44.16 (-1.25%)
MMAC : 27.77 (+0.04%)
SBBP : 2.00 (+1.52%)

Business Summary

Aerpio Pharmaceuticals Inc. is a biopharmaceutical company. It focuses on the development of novel therapeutics for vascular disorders with a concentration on diseases of the eye. The Company' product candidates include AKB'9778, ARP1536 and AKB-4924 which are in clinical stage. Aerpio Pharmaceuticals...

See More

Key Turning Points

3rd Resistance Point 2.42
2nd Resistance Point 2.36
1st Resistance Point 2.28
Last Price 33.00
1st Support Level 2.14
2nd Support Level 2.08
3rd Support Level 2.00

See More

Last Price 33.00
52-Week High 3.32
Fibonacci 61.8% 2.42
Fibonacci 50% 2.14
Fibonacci 38.2% 1.86
52-Week Low 0.95

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar